The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment - Nature Medicine

This work was supported by grants from the National Natural Science Foundation of China , the National Postdoctoral Program for Innovative Talents , the Overseas Expertise Introduction Project for Discipline Innovation, 111 Project , the Fundamental Research Funds for the Central Universities , the Natural Science Foundation of Guangdong Province , and the National Key R&D Program of China .

Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China Jiawei Lv, Yuan Wei, Yu-Pei Chen, Guan-Qun Zhou, Xiao-Yu Liang, Yuan Zhang, Shi-Wei He, Qing-Mei He, Jia-Yi Shen, Jun-Yan Li, Wen-Fei Li, Ling-Long Tang, Yan-Ping Mao, Rui Guo, Rui Sun, Na Liu, Dong-Ming Kuang, Ying Sun & Jun Ma

MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, ChinaJian-Hua Yin, Chen Wei, Cui-Juan Zhang, Zhuo-Li Huang, Yu-Hui Zheng, Wen-Wen Zhou, Ke-Xu Xiong, Si-Qi Wang, Xin Jin & Gui-Bo LiChen Wei, Zhuo-Li Huang & Yu-Hui Zheng CAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, ChinaDepartment of Respiratory Medicine, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Centre, State Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Inside the nascent industry of AI-designed drugs - Nature MedicineArtificial intelligence tools are beginning to upend the drug discovery pipeline, with several new compounds entering clinical trials.
Source: NatureMedicine - 🏆 451. / 53 Read more »

Researchers and regulators plan for a future without lab animals - Nature MedicineThe US Food and Drug Administration has reduced requirements for preclinical animal testing, leading to a surge of interest in organoids, tissue chips and in silico testing.
Source: NatureMedicine - 🏆 451. / 53 Read more »

Research software engineering accelerates the translation of biomedical research for health - Nature MedicineResearch software engineering accelerates the translation of biomedical research for health. Comment from Dave_Horsfall Muzz_Haniffa and colleagues sangerinstitute
Source: NatureMedicine - 🏆 451. / 53 Read more »

Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results - Nature MedicineIn patients with DNA damage response-deficient solid tumors, the oral ATR kinase inhibitor camonsertib was well tolerated; a recommended phase 2 dose was identified; and encouraging anti-tumor activity was observed, with the highest response rate observed in patients with ovarian cancer.
Source: NatureMedicine - 🏆 451. / 53 Read more »

Stanford Medicine Reveals: Tiny DNA Circles Defying Genetic Laws Drive Cancer FormationTiny circles of DNA harbor cancer-associated oncogenes and immunomodulatory genes promoting cancer development. They arise during the transformation from pre-cancer to cancer, say Stanford Medicine-led team. Tiny circles of DNA that defy the accepted laws of genetics are key drivers of cancer for
Source: SciTechDaily1 - 🏆 84. / 68 Read more »

Republicans should not help Bernie Sanders push socialized medicineThe Senate Committee on Health, Education, Labor and Pensions held a hearing last week about high prices for prescription drugs — specifically, insulin.
Source: WashTimes - 🏆 235. / 63 Read more »